Shorter vs longer radiation after breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial compares giving breast radiation over one week versus three weeks after surgery. It aims to see whether the shorter schedule works just as well and is safe for people with certain types of early breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older with invasive breast cancer confirmed by biopsy (not just pre-cancer cells).
- Have had curative surgery for breast cancer (either mastectomy or breast-conserving surgery) with clear margins.
- No spread of cancer to distant organs (doctors may order scans if your risk is high).
- Be well enough to complete treatment (your health status should be in a typical range, not severely limiting).
- Be eligible to receive “adjuvant” radiation (radiation given after surgery), based on your surgery results and tumor features.
- No prior radiation to the same side chest/breast area or the mediastinum, and no remaining cancer in certain nearby lymph nodes before starting radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a one-week radiation treatment to a three-week treatment for early-stage breast cancer. It aims to see if the shorter course is as effective and safe, potentially making treatment more convenient.
This trial compares two schedules of radiation after breast surgery in people with high-risk, node-positive breast cancer. The goal is to see whether giving radiation in 1 week or 2 weeks works well and is safe after standard treatments.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
This trial compares a shorter, one-week course of radiation to the standard two-week course after a lumpectomy for early-stage breast cancer. The goal is to see if one week is just as effective and safe, making treatment more convenient.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
This trial compares a shorter course of radiation (fewer, larger doses) with the standard longer course for women who have had breast cancer surgery with implant-based reconstruction. It aims to see if the shorter schedule is just as safe and effective for the chest area, while being more convenient.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.